DataMEDS AI Inc MEDS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
DataMEDS AI Enters Into Agreement for Commercial Supply of Six Peptides Recommended by FDA Advisory Committee
-
DataMEDS AI Establishes "Health Lives Here" Community Respiratory Program for Corexa Health Pharmacy Network
-
DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies
-
DataMeds Regains Compliance With NASDAQ Listing Standards
-
DataMeds Applauds FDA's Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health's Peptides Roadmap
-
DataMEDS Si Licenses U.S. Rights To Reboot Health AI's Direct-To-Consumer GLP-1 Weight Management Platform
-
DataMEDS SI Provides Business Update On CLIA Lab Helomics And Its Super Intelligence Predictive Oncology Division
-
DataMEDS SI Announces Helomics Receives Medicaid Coverage Policy For Chemofx(R) Assay In Gynecologic Cancers
Trading Information
- Previous Close Price
- $1.92
- Day Range
- $1.72–2.02
- 52-Week Range
- $0.82–38.50
- Bid/Ask
- $1.80 / $1.85
- Shares Outstanding
- 5.18M
- Market Cap
- $8.26M
- Volume/Avg
- 487,861 / 6M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.48
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
DataMEDS AI Inc is a healthcare technology and pharmaceutical logistics company. The group simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. Its solutions provide a single, integrated platform for pharmacies, wholesale distribution, and a fulfillment network focused on Independent Pharmacies and Specialty Lite medications.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Small Growth
- Total Number of Employees
- —
- Website
- https://wellgisticshealth.com
Valuation
|
Metric
|
MEDS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.48 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
MEDS
|
|---|---|
Quick Ratio | 0.09 |
Current Ratio | 0.14 |
Interest Coverage | −13.87 |
Quick Ratio
MEDS
Profitability
|
Metric
|
MEDS
|
|---|---|
Return on Assets (Normalized) | −85.79% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −144.82% |
Return on Assets
MEDS
Medical Distribution Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| McKesson Corp
MCK
| LOCK|<Fn>>C | LOCK|bgFFc | $116B | |||
| Cencora Inc
COR
| LOCK|@$R<>>F | LOCK|<CL^^ | $63B | |||
| Cardinal Health Inc
CAH
| LOCK|@l%g%C | LOCK|!hX>y | $58B | |||
| Sigma Healthcare Ltd
SIGGF
| — | LOCK|#JtN | $22B | |||
| Henry Schein Inc
HSIC
| LOCK|@!MRDQ | LOCK|<ZN< | $9B | |||
| Shanghai Pharmaceuticals Holding Co Ltd ADR
SHPMY
| — | LOCK|hK | $8B | |||
| Sinopharm Group Co Ltd ADR
SHTDY
| — | LOCK|zJ? | $6B | |||
| Sinopharm Group Co Ltd
SHTDF
| — | LOCK|nr | $6B | |||
| Galenica Ltd
GALNF
| — | LOCK|!#>! | $5B | |||
| Medipal Holdings Corp
MEPDF
| — | LOCK|F? | $4B |
United States